Trial Profile
A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two Doses of GW433908Ritonavir Given With Abacavir/Lamivudine Fixed Dose Combination.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Sep 2023
Price :
$35
*
At a glance
- Drugs Fosamprenavir (Primary) ; Lamivudine/abacavir; Ritonavir
- Indications HIV infections; HIV-1 infections
- Focus Pharmacodynamics; Therapeutic Use
- 30 Jan 2009 New trial record.